A detailed history of Voya Investment Management LLC transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Voya Investment Management LLC holds 722,065 shares of SWTX stock, worth $27 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
722,065
Previous 630,948 14.44%
Holding current value
$27 Million
Previous $23.8 Million 2.66%
% of portfolio
0.03%
Previous 0.03%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$32.04 - $42.76 $2.92 Million - $3.9 Million
91,117 Added 14.44%
722,065 $23.1 Million
Q2 2024

Aug 14, 2024

BUY
$36.06 - $47.62 $1.83 Million - $2.42 Million
50,851 Added 8.77%
630,948 $23.8 Million
Q1 2024

May 15, 2024

BUY
$36.5 - $52.5 $19.5 Million - $28.1 Million
534,577 Added 1174.38%
580,097 $28.6 Million
Q4 2023

Feb 14, 2024

BUY
$18.94 - $37.24 $67,407 - $132,537
3,559 Added 8.48%
45,520 $1.66 Million
Q3 2023

Nov 14, 2023

BUY
$23.12 - $31.38 $5,386 - $7,311
233 Added 0.56%
41,961 $970,000
Q2 2023

Aug 14, 2023

BUY
$23.15 - $32.71 $221,915 - $313,558
9,586 Added 29.82%
41,728 $1.09 Million
Q1 2023

May 15, 2023

SELL
$24.97 - $34.05 $1.84 Million - $2.51 Million
-73,705 Reduced 69.63%
32,142 $827,000
Q3 2022

Nov 14, 2022

BUY
$24.1 - $39.66 $2.24 Million - $3.68 Million
92,869 Added 715.59%
105,847 $3.02 Million
Q2 2022

Aug 15, 2022

BUY
$18.36 - $60.07 $28,825 - $94,309
1,570 Added 13.76%
12,978 $320,000
Q4 2021

Feb 14, 2022

SELL
$53.3 - $75.84 $266 - $379
-5 Reduced 0.04%
11,408 $707,000
Q2 2021

Aug 16, 2021

BUY
$67.45 - $85.63 $59,221 - $75,183
878 Added 8.33%
11,413 $941,000
Q1 2021

May 17, 2021

BUY
$65.1 - $93.59 $32,289 - $46,420
496 Added 4.94%
10,535 $775,000
Q4 2020

Feb 16, 2021

BUY
$48.36 - $77.92 $130,040 - $209,526
2,689 Added 36.59%
10,039 $728,000
Q2 2020

Aug 14, 2020

BUY
$22.98 - $48.57 $168,903 - $356,989
7,350 New
7,350 $309,000

Others Institutions Holding SWTX

About SpringWorks Therapeutics, Inc.


  • Ticker SWTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,401,100
  • Market Cap $2.34B
  • Description
  • SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...
More about SWTX
Track This Portfolio

Track Voya Investment Management LLC Portfolio

Follow Voya Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.